Packaging container with anti-crystallization function

Abstract

The utility model relates to the field of medical supplies, and discloses a packaging container with an anti-crystallization function, which comprises a base and a plurality of mannitol injection bottles, a connecting seat is fixedly arranged at the upper end of the base, a rotating rod is rotatably arranged on the inner bottom surface of the connecting seat, and three rotating cylinders are rotatably arranged on the periphery of the rotating rod. And four connecting columns are fixedly arranged on the peripheries of the three rotating cylinders correspondingly, placing boxes are fixedly arranged at one ends of the multiple connecting columns correspondingly, and shells are arranged on the peripheries of the multiple mannitol injection bottles in a penetrating mode correspondingly. According to the mannitol injection bottle storage device, mannitol injection bottles are placed in the storage boxes, so that the mannitol injection bottles are not affected by the outside to be collided and damaged in the storage process, the safety of the mannitol injection bottles is greatly improved, the multiple storage boxes are rotationally arranged on the periphery of the rotating rod, the multiple storage boxes can rotate and revolve, and the mannitol injection bottles can be stored conveniently. And medical staff can conveniently observe and take the mannitol injection bottle.

Description

Technical Field

[0001] This utility model relates to the field of medical supplies, and in particular to a packaging container with anti-crystallization function. Background Technology

[0002] Mannitol injection is used to treat cerebral edema caused by various reasons, reduce intracranial pressure, and prevent brain herniation. Mannitol injection can be stored stably at room temperature of 20-30℃ without change. However, once the room temperature drops below 25℃, crystallization tends to occur. When the room temperature drops below 20℃, about 10% of the mannitol injection will crystallize, and this crystallization rate is more obvious in winter, affecting the efficacy and safety of the drug.

[0003] A search revealed an existing patent (publication number: CN210277731U) entitled "This utility model discloses a silicone temperature measuring protective sleeve for mannitol injection, including a protective sleeve body. The two ends of the protective sleeve body are gradually narrowed inward to form a sleeve opening and a sleeve bottom. The diameter of the protective sleeve body is larger than the diameter of the sleeve bottom, and the diameter of the sleeve bottom is larger than the diameter of the sleeve opening. A suspension device is connected to the sleeve bottom. The beneficial effects of this utility model are: low cost and simple, which can solve the problem that the drug label is damaged or falls off after being soaked in water during the melting of mannitol injection in heating water tanks in secondary general hospitals and rice cookers in households, making it impossible to identify the drug information. It can provide information on the temperature of mannitol injection that is to be used immediately after heating and melting. At the same time, nurses can hang it directly on the infusion stand during clinical operations, saving time and effort. It is suitable for use in most clinical departments of secondary general hospitals in northern China."

[0004] While this patented technology allows for the direct suspension of heated mannitol injection solution on an infusion stand, it presents several drawbacks for storage: 1. The aforementioned patent cannot guarantee that the mannitol injection solution bottles will not be damaged by external impacts during storage, significantly reducing their safety; 2. When multiple mannitol injection solution bottles are stored, the aforementioned patent makes it difficult for medical personnel to easily observe and retrieve them. Therefore, those skilled in the art have developed a packaging container with anti-crystallization capabilities to address the problems mentioned in the background section. Utility Model Content

[0005] The purpose of this invention is to address the shortcomings of existing technologies by proposing a packaging container with anti-crystallization function. The mannitol injection bottle is placed in the placement box, which prevents the mannitol injection bottle from being damaged by collisions during storage, greatly improving the safety of the mannitol injection bottle. Multiple placement boxes are rotatably arranged around the rotating rod, allowing the multiple placement boxes to rotate both on their own axis and around the revolution, making it convenient for medical staff to observe and retrieve the mannitol injection bottle.

[0006] To achieve the above objectives, the present invention provides the following technical solution:

[0007] A packaging container with anti-crystallization function includes a base and multiple mannitol injection bottles. A connecting seat is fixedly provided on the upper end of the base. A rotating rod is rotatably provided on the inner bottom surface of the connecting seat. Three rotating cylinders are rotatably provided around the rotating rod. Four connecting posts are fixedly provided around the three rotating cylinders.

[0008] Each of the multiple connecting columns has a fixed placement box at one end. Each of the multiple placement boxes includes a fixed base, a handle, a squeeze ball, two connecting rods, and two locking blocks. Each of the multiple mannitol injection bottles has a shell extending through its periphery.

[0009] Through the above technical solution, the connecting seat facilitates the rotation of the rotating rod, the rotating rod facilitates the rotation of the three rotating cylinders, the three rotating cylinders facilitate the rotation of multiple connecting columns, the multiple connecting columns facilitate the rotation of multiple placement boxes, and the multiple outer shells facilitate the filling of aerobic heating chemicals.

[0010] Furthermore, a sealing gasket is fixedly fitted around the upper end of each of the mannitol injection bottles, and a support base is fixedly installed on the inner walls of both sides of the inner bottom surface of each of the outer shells. The gap between the mannitol injection bottles and the outer shells is filled with an aerobic heating chemical.

[0011] Through the above technical solution, the multiple sealing gaskets enhance the sealing performance between the outer periphery of the upper bottle opening of the multiple mannitol injection bottles and the openings at the middle position of the upper part of the multiple outer shells. The multiple support seats facilitate the support of the multiple mannitol injection bottles respectively. The aerobic heating chemical body facilitates temperature control and prevents the mannitol injection from crystallizing during storage and use.

[0012] Furthermore, an oxygen inlet pipe is provided through one side of the upper end of each of the multiple outer shells, and a direct-control solenoid valve is connected to the upper end of each of the multiple oxygen inlet pipes. An oxygen contact connector is connected to the oxygen inlet of each of the multiple direct-control solenoid valves.

[0013] Through the above technical solution, the multiple direct-control solenoid valves can easily control the amount of oxygen entering the multiple housings, and the multiple oxygen-contact connectors can easily deliver oxygen from the air into the housings.

[0014] Furthermore, each of the multiple oxygen contact connectors is movably provided with a first cover at its upper end, and each of the multiple outer shells is provided with an oxygen extraction tube through its lower end on one side.

[0015] Through the above technical solution, the multiple first covers prevent dust and air from entering the multiple oxygen contact joints when not in use, and the multiple oxygen extraction tubes facilitate the delivery of oxygen.

[0016] Furthermore, one end of each of the multiple oxygen extraction tubes is connected to a one-way valve, the oxygen extraction ports of each of the multiple one-way valves are connected to an oxygen extraction connector, and one end of each of the multiple oxygen extraction connectors is movably provided with a second cover.

[0017] Through the above technical solution, the multiple one-way valves ensure that there is no accidental contact with oxygen during the oxygen extraction process, the multiple oxygen extraction connectors facilitate connection to the oxygen pump, and the multiple second covers prevent dust and air from entering the multiple oxygen extraction connectors when not in use.

[0018] Furthermore, a temperature monitoring meter is fixedly installed at the upper end of the front end of each of the multiple outer shells, an adjustment panel is fixedly installed at the middle end of the front end of each of the multiple outer shells, and a slot is opened at the lower end of the front and rear ends of each of the multiple outer shells.

[0019] Through the above technical solution, the multiple temperature monitoring gauges facilitate real-time monitoring of mannitol temperature, the multiple adjustment panels facilitate adjustment of the reaction rate of the heated chemical as needed, ensuring that mannitol is within a suitable temperature range and will not have an adverse effect on the drug, and the multiple slots facilitate multiple placement boxes to fix multiple outer shells respectively.

[0020] Furthermore, the fixed base is fixedly installed at one end of the connecting column, and the two locking blocks are movably embedded in the inner wall of one side of the bottom surface of the fixed base. The two connecting rods movably pass through the lower ends of the two locking blocks, and the two ends of the two connecting rods are fixedly installed at the lower ends of the inner walls on both sides of the fixed base.

[0021] Through the above technical solution, the fixing seat facilitates the placement of the outer shell, the two locking blocks facilitate the insertion into the two locking slots, thereby fixing the outer shell, and the two connecting rods respectively support the two locking blocks, allowing the two locking blocks to rotate.

[0022] Furthermore, the throttle is threaded onto the lower end of the fixed base near one side, the compression ball is fixedly disposed at the upper end of the throttle, and the compression ball moves through the lower end of the two locking blocks on opposite sides.

[0023] Through the above technical solution, the rotation of the throttle facilitates the up-and-down movement of the extrusion ball, and the up-and-down movement of the extrusion ball facilitates the two locking blocks to engage with and disengage from the two locking slots.

[0024] This utility model has the following beneficial effects:

[0025] 1. This utility model proposes a packaging container with anti-crystallization function. The mannitol injection bottle is installed inside the outer shell. The outer shell is placed on the inner bottom surface of the fixing base, and the two slots are parallel to the upper ends of the two locking blocks. Rotating the handle moves the squeezing ball downward, causing the upper ends of the two locking blocks to squeeze inward, so that the upper ends of the two locking blocks are respectively locked into the two slots, thereby fixing the outer shell. This prevents the mannitol injection bottle from being damaged by collisions during storage, greatly improving the safety of the mannitol injection bottle.

[0026] 2. The present invention proposes a packaging container with anti-crystallization function. Rotating the rotating rod drives three rotating cylinders to rotate, which in turn drives multiple connecting columns to rotate, which in turn drives multiple placement boxes to rotate, realizing the revolution of the placement boxes. Rotating one of the multiple placement boxes drives one of the multiple connecting columns to rotate, which in turn drives one of the three rotating cylinders to rotate, making the three rotating cylinders rotate, which facilitates medical staff to observe and take out mannitol injection bottles. Attached Figure Description

[0027] Figure 1 This is an axonometric view of the present invention.

[0028] Figure 2 This is a top view of the present invention.

[0029] Figure 3 This is an axial side view of the housing proposed in this utility model;

[0030] Figure 4 This is a cross-sectional view of the outer shell proposed in this utility model;

[0031] Figure 5 This is a schematic diagram of the placement box axial side according to the present invention;

[0032] Figure 6 This is a side sectional view of the placement box proposed in this utility model.

[0033] Legend:

[0034] 1. Rotating rod; 2. Outer shell; 3. Placement box; 301. Fixing base; 302. Rotating handle; 303. Squeezing ball; 304. Connecting rod; 305. Locking block; 4. Connecting seat; 5. Base; 6. Rotating cylinder; 7. Connecting column; 8. First cover; 9. Solenoid valve; 10. Oxygen contact connector; 11. One-way valve; 12. Second cover; 13. Slot; 14. Adjustment panel; 15. Temperature monitor; 16. Sealing gasket; 17. Aerobic heating chemical; 18. Oxygen extraction connector; 19. Support base; 20. Mannitol injection bottle; 21. Oxygen inlet pipe; 22. Oxygen extraction pipe. Detailed Implementation

[0035] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings of the embodiments. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.

[0036] Reference Figure 1-6 An embodiment of this utility model is provided: a packaging container with anti-crystallization function, including a base 5 and multiple mannitol injection bottles 20. A connecting seat 4 is fixedly provided on the upper end of the base 5. A rotating rod 1 is rotatably provided on the inner bottom surface of the connecting seat 4. Three rotating cylinders 6 are rotatably provided on the outer periphery of the rotating rod 1. Four connecting columns 7 are fixedly provided on the outer periphery of each of the three rotating cylinders 6.

[0037] Each of the multiple connecting posts 7 has a fixed placement box 3 at one end. Each of the multiple placement boxes 3 includes a fixed base 301, a handle 302, a squeeze ball 303, two connecting rods 304, and two locking blocks 305. Rotating the rotating rod 1 drives the three rotating cylinders 6 to rotate, which in turn drives the multiple connecting posts 7 to rotate, which in turn drives the multiple placement boxes 3 to rotate, thus realizing the revolution of the placement boxes 3. Rotating one of the multiple placement boxes 3 drives one of the multiple connecting posts 7 to rotate, which in turn drives one of the three rotating cylinders 6 to rotate, thus making the three rotating cylinders 6 rotate on their own axis. Each of the multiple mannitol injection bottles 20 has a shell 2 that runs through its periphery. Plastic or glass can be used as the material for the shell 2. If plastic is chosen, its high temperature resistance should be given special consideration.

[0038] It is known that a sealing gasket 16 is fixedly fitted around the upper bottle opening of multiple mannitol injection bottles 20, and a support seat 19 is fixedly installed on the inner walls of both sides of the inner bottom surface of multiple outer shells 2. The gap between multiple mannitol injection bottles 20 and multiple outer shells 2 is filled with an aerobic heating chemical 17. An oxygen inlet pipe 21 is installed through one side of the upper end of multiple outer shells 2. A direct control solenoid valve 9 is connected to the upper end of multiple oxygen inlet pipes 21. An oxygen contact connector 10 is connected to the oxygen inlet of multiple direct control solenoid valves 9. A first cap 8 is movably installed at the upper end of multiple oxygen contact connectors 10. An oxygen extraction pipe 22 is installed through one side of the lower end of multiple outer shells 2. A one-way valve 11 is connected to one end of multiple oxygen extraction pipes 22. An oxygen extraction connector 18 is connected to the oxygen extraction port of multiple one-way valves 11. A second cap 12 is movably installed at one end of multiple oxygen extraction connectors 18.

[0039] Open the direct-control solenoid valve 9 and the first cover 8 to allow oxygen in the air to enter the housing 2 through the oxygen contact connector 10 and the direct-control solenoid valve 9. The oxygen-demanding heating chemical 17 can be a polymer particle synthesized from iron, activated carbon, inorganic salts, water, etc. It is sufficient to release heat through a chemical reaction when it comes into contact with oxygen. Under the action of oxygen in the air, heat is continuously released, thereby preventing mannitol injection from crystallizing during storage and use. When heating is not required, open the second cover 12 on the oxygen pump connector 18 and connect the oxygen pump to the oxygen pump connector 18 to extract the air from the housing 2, end the chemical reaction, and stop the heating process.

[0040] According to the above, temperature monitoring gauges 15 are fixedly installed at the upper front end of multiple shells 2, adjustment panels 14 are fixedly installed at the middle front end of multiple shells 2, and slots 13 are opened at the lower front and rear ends of multiple shells 2. The temperature of mannitol is monitored in real time through temperature monitoring gauges 15 and adjustment panels 14, and the reaction rate of the heated chemical is adjusted as needed. The fixed base 301 is fixedly installed at one end of the connecting column 7. Two locking blocks 305 are movably embedded in the inner wall of the bottom side of the fixed base 301. Two connecting rods 304 are movably inserted through the lower ends of the two locking blocks 305, and the lower ends of the two connecting rods 304 are fixedly installed on the lower ends of the inner walls on both sides of the fixed base 301.

[0041] It can be seen that the throttle 302 is threaded onto the lower end of the fixed base 301 on one side, and the compression ball 303 is fixedly set on the upper end of the throttle 302. The compression ball 303 is movably inserted through the lower end of the two locking blocks 305 on opposite sides. The outer shell 2 is placed on the inner bottom surface of the fixed base 301, and the two locking slots 13 are parallel to the upper ends of the two locking blocks 305 respectively. Rotating the throttle 302 causes the compression ball 303 to move downward, causing the upper ends of the two locking blocks 305 to be squeezed inward respectively, so that the upper ends of the two locking blocks 305 are respectively locked into the two locking slots 13, thereby fixing the outer shell 2.

[0042] Working principle: The mannitol injection bottle 20 is installed inside the outer casing 2. When it is necessary to prevent mannitol crystallization, the direct-control solenoid valve 9 is opened, and the first cap 8 is opened to allow oxygen from the air to enter the interior of the outer casing 2 through the oxygen-contact connector 10 and the direct-control solenoid valve 9. This oxygen reacts with the oxygen-required heating chemical 17, thereby preventing the mannitol injection from crystallizing during storage and use. When heating is not required, the second cap 12 on the oxygen-contact connector 18 is opened, and the oxygen pump is connected to the oxygen-contact connector 18 to extract the air from the outer casing 2, ending the chemical reaction and stopping the heating process. The outer casing 2 is then placed on the inner bottom surface of the fixing base 301, with both... The slots 13 are parallel to the upper ends of the two locking blocks 305. Rotating the handle 302 causes the squeezing ball 303 to move downward, causing the upper ends of the two locking blocks 305 to squeeze inward, so that the upper ends of the two locking blocks 305 are respectively locked into the two slots 13, thereby fixing the outer shell 2. Rotating the rotating rod 1 causes the three rotating cylinders 6 to rotate, which in turn causes the multiple connecting columns 7 to rotate, which in turn causes the multiple placement boxes 3 to rotate, realizing the revolution of the placement boxes 3. Rotating one of the multiple placement boxes 3 causes one of the multiple connecting columns 7 to rotate, which in turn causes one of the three rotating cylinders 6 to rotate, making the three rotating cylinders 6 rotate, which facilitates medical staff to observe and take the mannitol injection bottle 20.

[0043] Finally, it should be noted that the above description is only a preferred embodiment of the present utility model and is not intended to limit the present utility model. Although the present utility model has been described in detail with reference to the foregoing embodiments, those skilled in the art can still modify the technical solutions described in the foregoing embodiments or make equivalent substitutions for some of the technical features. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present utility model should be included within the protection scope of the present utility model.

Claims

1. A packaging container with anti-crystallization function, comprising a base (5) and a plurality of mannitol injection bottles (20), characterized in that: A connecting seat (4) is fixedly provided at the upper end of the base (5); a rotating rod (1) is rotatably provided on the inner bottom surface of the connecting seat (4); three rotating cylinders (6) are rotatably provided on the periphery of the rotating rod (1); and four connecting columns (7) are fixedly provided on the periphery of each of the three rotating cylinders (6); A placement box (3) is fixedly arranged at one end of each of the plurality of connecting columns (7), and each of the plurality of placement boxes (3) comprises a fixing seat (301), a turning handle (302), a squeezing ball (303), two connecting rods (304) and two clamping blocks (305). A shell (2) is penetrated through the periphery of each of the plurality of mannitol injection bottles (20).

2. The packaging container with anti-crystallization function according to claim 1, characterized in that: A sealing gasket (16) is fixedly provided on the outer periphery of the upper end of each of the mannitol injection bottles (20); support seats (19) are fixedly provided on the inner walls on both sides of the inner bottom surface of each of the outer shells (2); and the gaps between the mannitol injection bottles (20) and the outer shells (2) are filled with an aerobic heating chemical (17).

3. The packaging container with anti-crystallization function according to claim 1, characterized in that: An oxygen inlet pipe (21) is provided through the upper ends of the plurality of housings (2) at one side, the upper ends of the plurality of oxygen inlet pipes (21) are connected to a directly controlled electromagnetic valve (9), and the oxygen inlets of the plurality of directly controlled electromagnetic valves (9) are connected to an oxygen contact joint (10).

4. The packaging container with anti-crystallization function according to claim 3, characterized in that: A first cover (8) is movably provided at the upper end of each of the plurality of oxygen contact joints (10), and an oxygen extraction pipe (22) is penetrated and provided at the lower end of each of the plurality of shells (2).

5. The packaging container with anti-crystallization function according to claim 4, characterized in that: One end of each of the plurality of oxygen extraction pipes (22) is connected to a one-way valve (11), oxygen extraction ports of each of the plurality of one-way valves (11) are connected to an oxygen extraction connector (18), and one end of each of the plurality of oxygen extraction connectors (18) is movably provided with a second cover (12).

6. The packaging container with anti-crystallization function according to claim 1, characterized in that: A temperature monitor (15) is fixedly provided at the upper end of the front end of each of the plurality of shells (2), an adjustment panel (14) is fixedly provided at the middle end of the front end of each of the plurality of shells (2), and a card slot (13) is provided at the lower end of the front end and the rear end of each of the plurality of shells (2).

7. The packaging container with anti-crystallization function according to claim 1, characterized in that: The fixing seat (301) is fixedly arranged at one end of the connecting column (7), the two clamping blocks (305) are movably embedded in the inner wall position of one side of the inner bottom surface of the fixing seat (301), the two connecting rods (304) are movably penetrated at the lower ends of the two ends of the two clamping blocks (305), and the two ends of the two connecting rods (304) are fixedly arranged at the lower ends of the inner walls of both sides of the fixing seat (301).

8. The packaging container with anti-crystallization function according to claim 1, characterized in that: The turning handle (302) is threadedly sleeved on the lower end of the fixing seat (301) near one side, and the squeezing ball (303) is fixedly arranged on the upper end of the turning handle (302), and the squeezing ball (303) movably penetrates the lower end of the opposite side of the two clamping blocks (305).

Images